Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 19

CN4 - iGestSaúde: Portuguese mobile application for the self-management of symptoms associated with chemotherapy treatment

Date

10 Sep 2022

Session

Poster session 19

Topics

Supportive Care and Symptom Management;  Cancer Intelligence (eHealth, Telehealth Technology, BIG Data)

Tumour Site

Presenters

Bruno Magalhaes

Citation

Annals of Oncology (2022) 33 (suppl_7): S808-S811. 10.1016/annonc/annonc1041

Authors

B. Magalhaes1, C. Fernandes2, C. Santos2

Author affiliations

  • 1 Department Of Surgical Oncology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-162 - Porto/PT
  • 2 Nursing, Escola Superior de Enfermagem do Porto, 4200-072 - Porto/PT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN4

Background

People with oncologic disease undergoing chemotherapy treatment refer the need to promote the process of self-management of the disease and the symptoms associated with the treatment. This study aims to describe the development of a mobile application (APP) that support the self-management of the symptoms associated with chemotherapy treatment and strengthen communication between patients and health professionals: the iGestSaúde.

Methods

The research is divided into six stages, using an exploratory/descriptive pilot study conducted over 36 months. The stages include research and fundamentals, development, validation of therapeutic guidelines, field study, technological development, implementation, and mobile application evaluation.

Results

The project will monitor and improve patients' compliance to chemotherapy, to prevent chemotherapy associated complications through preventive indications for self-care, and to improve patients' responses to uncontrolled symptoms or complications. And also, favor adherence to therapeutic indications and answering to the symptoms or complications that may appear associated with the disease. The development of this APP may improve the quality of life of these patients and promote an alternative and efficient way of communication with healthcare professionals. APPs should be tested outside the academic environment, outreaching this group of people, allowing to effectively investigate its applicability and to assess the impact of this “new” technological intervention options. Particularly in this case with therapeutic guidelines validated by healthcare professionals.

Conclusions

APPs can be considered a viable and effective tool for self-management of complications associated with chemotherapy treatment, supported by scientific evidence and these people's specific needs. Despite the recent technological advancements, namely in the design of applications targeting the healthcare area, they lack scientific rigor, particularly in what concern the development of their contents and adequate sustainability, which is the great asset of this project. The proposed solution presented in this study, based on the knowledged obtained by focusing on people’s needs, intended to be the starting point to important contributions for the improvement of knowledge associated with the nursing discipline and the excellence of nursing care in people with cancer undergoing chemotherapy.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.